- Home
- OVV vs RVMD Comparison
OVV vs RVMD Comparison
Compare OVV & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OVV | RVMD |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 15.2B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | OVV | RVMD |
|---|---|---|
| Price | $55.73 | $99.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 17 |
| Target Price | $53.08 | ★ $116.12 |
| AVG Volume (30 Days) | ★ 4.6M | 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | ★ 13.54 | N/A |
| EPS | ★ 4.78 | N/A |
| Revenue | ★ $8,908,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.47 | $454.85 |
| P/E Ratio | $11.71 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $29.80 | $29.17 |
| 52 Week High | $56.18 | $124.49 |
Technical Indicators
Market Signals| Indicator | OVV | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 73.12 | 51.65 |
| Support Level | $36.96 | $93.59 |
| Resistance Level | N/A | $107.45 |
| Average True Range (ATR) | 1.55 | 3.76 |
| MACD | 0.08 | -0.33 |
| Stochastic Oscillator | 93.92 | 54.33 |
Price Performance
Historical ComparisonAbout OVV Ovintiv Inc. (DE)
Ovintiv Inc is a North American oil and natural gas exploration and production company focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs, and natural gas. The company has two operating segments: USA Operations and Canadian Operations. USA Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within the United States. Canadian Operations include the exploration, development, production, and marketing of oil, NGLs, natural gas, and other related activities within Canada. The company generates the majority of its revenue from USA Operations.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.